Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Medtronic PLC (MDT : NYSE)
 
 • Company Description   
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.

Number of Employees: 90,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $106.26 Daily Weekly Monthly
20 Day Moving Average: 4,916,811 shares
Shares Outstanding: 1,341.54 (millions)
Market Capitalization: $142,551.95 (millions)
Beta: 0.74
52 Week High: $135.89
52 Week Low: $98.38
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -3.59% 5.21%
12 Week 2.45% 7.86%
Year To Date 2.72% 19.73%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
20 ON HATCH LOWER HATCH STREET
-
DUBLIN,L2 D02
IRL
ph: 353-1438-1700
fax: 763-514-4879
investor.relations@medtronic.com http://www.medtronic.com
 
 • General Corporate Information   
Officers
Geoffrey S. Martha - Chairman and Chief Executive Officer
KarenL. Parkhill - Executive Vice President and Chief Financial Offic
Bradley E. Lerman - Senior Vice President; General Counsel and Corpora
Carol A. Surface - Senior Vice President and Chief Human Resources Of
Richard Kuntz - Senior Vice President and Chief Medical and Scient

Peer Information
Medtronic PLC (BJCT)
Medtronic PLC (CADMQ)
Medtronic PLC (APNO)
Medtronic PLC (UPDC)
Medtronic PLC (IMTIQ)
Medtronic PLC (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: G5960L103
SIC: 3845
Fiscal Year
Fiscal Year End: April
Last Reported Quarter: 01/01/22
Next Expected EPS Date: 05/26/22
Share - Related Items
Shares Outstanding: 1,341.54
Most Recent Split Date: 9.00 (2.00:1)
Beta: 0.74
Market Capitalization: $142,551.95 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 2.37%
Current Fiscal Quarter EPS Consensus Estimate: $1.39 Indicated Annual Dividend: $2.52
Current Fiscal Year EPS Consensus Estimate: $5.81 Payout Ratio: 0.45
Number of Estimates in the Fiscal Year Consensus: 13.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 7.56% Last Dividend Paid: 03/24/2022 - $0.63
Next EPS Report Date: 05/26/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 18.29
Trailing 12 Months: 18.98
PEG Ratio: 2.42
Price Ratios
Price/Book: 2.71
Price/Cash Flow: 22.62
Price / Sales: 4.48
EPS Growth
vs. Year Ago Period: 6.20%
vs. Previous Quarter: 3.79%
Sales Growth
vs. Year Ago Period: -0.15%
vs. Previous Quarter: -1.07%
ROE
04/30/22 - -
01/31/22 - 14.57
10/31/21 - 14.52
ROA
04/30/22 - -
01/31/22 - 8.23
10/31/21 - 8.01
Current Ratio
04/30/22 - -
01/31/22 - 2.61
10/31/21 - 2.91
Quick Ratio
04/30/22 - -
01/31/22 - 2.10
10/31/21 - 2.36
Operating Margin
04/30/22 - -
01/31/22 - 23.86
10/31/21 - 23.56
Net Margin
04/30/22 - -
01/31/22 - 15.46
10/31/21 - 14.80
Pre-Tax Margin
04/30/22 - -
01/31/22 - 17.24
10/31/21 - 16.08
Book Value
04/30/22 - -
01/31/22 - 39.21
10/31/21 - 38.81
Inventory Turnover
04/30/22 - -
01/31/22 - 2.34
10/31/21 - 2.38
Debt-to-Equity
04/30/22 - -
01/31/22 - 0.46
10/31/21 - 0.49
Debt-to-Capital
04/30/22 - -
01/31/22 - 31.54
10/31/21 - 32.93
 

Powered by Zacks Investment Research ©